The Patent Finder

Ose Immunotherapeutics

Also on record
Records under this name other than the patents Ose Immunotherapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 28 patents it holds.

Showing 1 to 5 of 5 · Back to Ose Immunotherapeutics

PatentTitleStatus Expires Confidence
US 9,562,098Anti-CD28 Humanized Antibodies
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,365,257Methods for Promoting T Cells Response by Administering an Antagonist of Human C-Type Lectin-Like Receptor 1 (CLEC-1)
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,077,820Biomarkers for Assessing the Response Status for Treatment of Inflammatory Condition or Disease Affecting the Digestive Tract Such as Inflammatory Bowel Disease in Human Patients
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,448,454Humanized ANTI-CLEC-1A Antibodies and Antigen-Binding Fragments Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,301,955Tritoqualine for use in the treatment of cystic fibrosis
Lapsed on the fee record
Ended Apr 5, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 5, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited